Healthcare infection Target hospitals and surgical centers with a strong focus on reducing hospital-acquired infections. Leverage Aerobiotix's established messaging around air quality and environmental safety to position as a strategic partner for infection prevention programs and ISO-certified environments.

Partnership leverage Capitalize on existing and past collaborations (Cardinal Health, APIC) to approach large health systems and distributors. Use proven case studies and investor activity as credibility signals to accelerate dialogue with procurement, risk, and infection control stakeholders.

Seal of recognition Promote the IRIS Healthcare Air Quality Seal of Recognition program to drive tiered adoption across facilities. Offer implementation support and measurable impact metrics to facilities seeking recognized standards for environmental safety and patient care quality.

Growth funding signals Highlight strong funding history and investor backing to reassure potential buyers about product longevity and roadmap. Position Aerobiotix as a scalable, long-term partner with ongoing product enhancements and expanded clinical validation opportunities.

Expansion opportunities Pursue industry events and conferences (AHVAP) as lead-generating channels and consider channel partnerships with distributors and equipment integrators. Emphasize data-driven insights and monitoring capabilities to differentiate from competitors and open upsell to broader facility safety programs.